<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39410969</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-8740</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in radiology</Title><ISOAbbreviation>Front Radiol</ISOAbbreviation></Journal><ArticleTitle>Seven-tesla magnetic resonance imaging of the nervus terminalis, olfactory tracts, and olfactory bulbs in COVID-19 patients with anosmia and hypogeusia.</ArticleTitle><Pagination><StartPage>1322851</StartPage><MedlinePgn>1322851</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1322851</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fradi.2024.1322851</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Linking olfactory epithelium to the central nervous system are cranial nerve 1, the olfactory nerve, and cranial nerve "0," and the nervus terminalis (NT). Since there is minimal expression of angiotensin-converting enzyme-2 (ACE-2) in the olfactory nerve, it is unclear how SARS-CoV-2 causes anosmia (loss of smell) and hypogeusia (reduction of taste). In animal models, NT expresses ACE-2 receptors, suggesting a possible SARS-CoV-2 viral entry site in humans. The purpose of this study was to determine whether ultra-high-field 7 T magnetic resonance imaging (MRI) could visualize the NT, olfactory bulbs (OB), and olfactory tract (OT) in healthy controls and COVID-19 anosmia or hypogeusia and to qualitatively assess for volume loss and T2 alterations.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this study, 7 T MRI was used to evaluate the brain and olfactory regions in 45 COVID-19 patients and 29 healthy controls. Neuroimaging was qualitatively assessed by four board-certified neuroradiologists who were blinded to outcome assignments: for the presence or absence of NT; for OB, OT, and brain volume loss; and altered T2 signal, white matter T2 hyperintensities, microhemorrhages, enlarged perivascular spaces, and brainstem involvement.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">NT was identifiable in all COVID-19 patients and controls. T2 hyperintensity in the NT, OB, and OT in COVID-19 patients with anosmia or hypogeusia was statistically significant compared to controls and COVID-19 patients without anosmia or hypogeusia.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">On 7 T MRI, NT was radiographically identifiable, adjacent to OB and OT. In COVID-19 anosmia and hypogeusia, T2 hyperintensity of NT, OB, and OT was statistically significant compared to COVID-19 patients without anosmia or hypogeusia and controls. The NT may be a potential entry site for SARs-CoV-2 and may play a role in the pathophysiology of COVID-19 anosmia.</AbstractText><CopyrightInformation>© 2024 Kirsch, Khurram, Lambert, Belani, Pawha, Alipour, Rashid, Herb, Saju, Zhu, Delman, Lin and Balchandani.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirsch</LastName><ForeName>Claudia F E</ForeName><Initials>CFE</Initials><AffiliationInfo><Affiliation>Yale Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The School of Clinical Dentistry, University of Sheffield, Sheffield, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khurram</LastName><ForeName>Syed Ali</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>The School of Clinical Dentistry, University of Sheffield, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The School of Clinical Dentistry, University of Sheffield, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belani</LastName><ForeName>Puneet</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawha</LastName><ForeName>Puneet S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alipour</LastName><ForeName>Akbar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Shams</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herb</LastName><ForeName>Mackenzie T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saju</LastName><ForeName>Sera</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yijuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delman</LastName><ForeName>Bradley N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hung-Mo</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balchandani</LastName><ForeName>Priti</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Radiol</MedlineTA><NlmUniqueID>9918367586306676</NlmUniqueID><ISSNLinking>2673-8740</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">angiotensin-converting enzyme 2 (ACE-2) receptor</Keyword><Keyword MajorTopicYN="N">hypothalamus</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging (MRI)</Keyword><Keyword MajorTopicYN="N">nervus terminalis (NT)</Keyword><Keyword MajorTopicYN="N">olfactory tract</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39410969</ArticleId><ArticleId IdType="pmc">PMC11473298</ArticleId><ArticleId IdType="doi">10.3389/fradi.2024.1322851</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. (2020) 581(7807):215–20. 10.1038/s41586-020-2180-52</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-52</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkotoky S, Dey D, Hazarika Z. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective. Mol Biol Rep. (2023) 50(3):2713–21. 10.1007/s11033-022-08193-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-08193-4</ArticleId><ArticleId IdType="pmc">PMC9786537</ArticleId><ArticleId IdType="pubmed">36562937</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. (2020) 17(1):231. 10.1186/s12974-020-01896-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01896-0</ArticleId><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181(2):271–80.e8. 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Streit S, Dittmayer C, Manitius RV, Radbruch H, Heppner FL. The neurobiology of SARS-CoV-2 infection. Nat Rev Neurosci. (2024) 25(1):30–42. 10.1038/s41583-023-00769-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-023-00769-8</ArticleId><ArticleId IdType="pubmed">38049610</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X, Pan Y. COVID-19 and anosmia: the story so far. Ear Nose Throat J. (2024) 103(5):NP312–20. 10.1177/01455613211048998</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613211048998</ArticleId><ArticleId IdType="pubmed">34587819</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R, Bilinska K, von Bartheld CS. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci. (2023) 46(1):75–90. 10.1016/j.tins.2022.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.11.003</ArticleId><ArticleId IdType="pmc">PMC9666374</ArticleId><ArticleId IdType="pubmed">36470705</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell'Aquila M, Cafiero C, Micera A, Stigliano E, Ottaiano MP, Benincasa G, et al. SARS-CoV-2-related olfactory dysfunction: autopsy findings, histopathology, and evaluation of viral RNA and ACE2 expression in olfactory bulbs. Biomedicines. (2024) 12(4):830. 10.3390/biomedicines12040830</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12040830</ArticleId><ArticleId IdType="pmc">PMC11048640</ArticleId><ArticleId IdType="pubmed">38672185</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper KW, Brann DH, Farruggia MC, Bhutani S, Pellegrino R, Tsukahara T, et al. COVID-19 and the chemical senses: supporting players take center stage. Neuron. (2020) 107(2):219–33. 10.1016/j.neuron.2020.06.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7328585</ArticleId><ArticleId IdType="pubmed">32640192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci. (2020) 11(11):1555–62. 10.1021/acschemneuro.0c00210</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukahara T, Brann DH, Datta SR. Mechanisms of SARS-CoV-2-associated anosmia. Physiol Rev. (2023) 103(4):2759–66. 10.1152/physrev.00012.2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00012.2023</ArticleId><ArticleId IdType="pmc">PMC10625840</ArticleId><ArticleId IdType="pubmed">37342077</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineda AG, Leon-Sarmiento FE, Doty RL. Cranial nerve 13. Handb Clin Neurol. (2019) 164:135–44. 10.1016/B978-0-444-63855-7.00009-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63855-7.00009-5</ArticleId><ArticleId IdType="pubmed">31604543</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand G. Olfactory/trigeminal interactions in nasal chemoreception. Neurosci Biobehav Rev. (2006) 30(7):908–17. 10.1016/j.neubiorev.2006.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2006.01.002</ArticleId><ArticleId IdType="pubmed">16545453</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin ZW, Cho KH, Shibata S, Yamamoto M, Murakami G, Rodríguez-Vázquez JF. Nervus terminalis and nerves to the vomeronasal organ: a study using human fetal specimens. Anat Cell Biol. (2019) 52(3):278–85. 10.5115/acb.19.020</Citation><ArticleIdList><ArticleId IdType="doi">10.5115/acb.19.020</ArticleId><ArticleId IdType="pmc">PMC6773908</ArticleId><ArticleId IdType="pubmed">31598357</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespo C, Liberia T, Blasco-Ibáñez JM, Nácher J, Varea E. Cranial pair I: the olfactory nerve. Anat Rec (Hoboken). (2019) 302(3):405–27. 10.1002/ar.23816</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.23816</ArticleId><ArticleId IdType="pubmed">29659152</ArticleId></ArticleIdList></Reference><Reference><Citation>Peña-Melián Á, Cabello-de la Rosa JP, Gallardo-Alcañiz MJ, Vaamonde-Gamo J, Relea-Calatayud F, González-López L, et al. Cranial pair 0: the nervus terminalis. Anat Rec (Hoboken). (2019) 302(3):394–404. 10.1002/ar.23826</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.23826</ArticleId><ArticleId IdType="pubmed">29663690</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilensky JA. The neglected cranial nerve: nervus terminalis (cranial nerve N). Clin Anat. (2014) 27(1):46–53. 10.1002/ca.22130</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ca.22130</ArticleId><ArticleId IdType="pubmed">22836597</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JB. The nervus terminalis in man and mammals. Anat. Rec. (1914) 8:185–98. 10.1002/ar.1090080402</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.1090080402</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsell O. The nervus terminalis. Ann Otol Rhinol Laryngol. (1950) 59(2):414–38. 10.1177/000348945005900211</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348945005900211</ArticleId><ArticleId IdType="pubmed">15426155</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Ojeda W, Hurley RA. Cranial nerve zero (CN 0): multiple names and often discounted yet clinically significant. J Neuropsychiatry Clin Neurosci. (2022) 34(2):A4–99. 10.1176/appi.neuropsych.22010021</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.22010021</ArticleId><ArticleId IdType="pubmed">35491548</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookover C. The peripheral distribution of the nervous terminalis in an infant. J Comp Neurol. (1917) 28 (2):349–60. 10.1002/cne.900280203</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.900280203</ArticleId></ArticleIdList></Reference><Reference><Citation>McCotter RE. A note on the course and distribution of the nervus terminalis in man. Anat Rec. (1915) 9:243–6. 10.1002/ar.1090090304</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.1090090304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K, von Bartheld CS, Butowt R. Expression of the ACE2 virus entry protein in the nervus terminalis reveals the potential for an alternative route to brain infection in COVID-19. Front Cell Neurosci. (2021) 15:674123. 10.3389/fncel.2021.674123</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.674123</ArticleId><ArticleId IdType="pmc">PMC8287262</ArticleId><ArticleId IdType="pubmed">34290590</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld CS, Butowt R. New evidence suggests SARS-CoV-2 neuroinvasion along the nervus terminalis rather than the olfactory pathway. Acta Neuropathol. (2024) 147(1):10. 10.1007/s00401-023-02664-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-023-02664-z</ArticleId><ArticleId IdType="pubmed">38183496</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitmore I. Terminologia anatomica: new terminology for the new anatomist. Anat Rec. (1999) 257(2):50–3.10.1002/(SICI)1097-0185(19990415)257:2&lt;50::AID-AR4&gt;3.0.CO;2-W</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0185(19990415)257:2&lt;50::AID-AR4&gt;3.0.CO;2-W</ArticleId><ArticleId IdType="pubmed">10321431</ArticleId></ArticleIdList></Reference><Reference><Citation>Biehl MJ, Raetzman LT. Developmental origins of hypothalamic cells controlling reproduction. Semin Reprod Med. (2017) 35(2):121–9. 10.1055/s-0037-159908328</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-159908328</ArticleId><ArticleId IdType="pubmed">28278530</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwanzel-Fukuda M. Origin and migration of luteinizing hormone-releasing hormone neurons in mammals. Microsc Res Tech. (1999) 44(1):2–10. 10.1002/(SICI)1097-0029(19990101)44:1&lt;2::AID-JEMT2&gt;3.0.CO;2-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0029(19990101)44:1&lt;2::AID-JEMT2&gt;3.0.CO;2-4</ArticleId><ArticleId IdType="pubmed">9915559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong WY, Satish RL, Herr DR. ACE2, circumventricular organs and the hypothalamus, and COVID-19. Neuromolecular Med. (2022) 24(4):363–73. 10.1007/s12017-022-08706-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-022-08706-1</ArticleId><ArticleId IdType="pmc">PMC9023728</ArticleId><ArticleId IdType="pubmed">35451691</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashmi KG, Perumal N, Cherian A, Wyawahare M, Prasad A, Sahoo J, et al. Hypothalamic-pituitary adrenal axis status 3 months after recovery from COVID-19 infection. Endocr Res. (2023) 48(4):85–93. 10.1080/07435800.2023.2245907</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07435800.2023.2245907</ArticleId><ArticleId IdType="pubmed">37565765</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato E, Jr, Taroc EZM, Forni PE. Illuminating the terminal nerve: uncovering the link between GnRH-1 neuron and olfactory development. J Comp Neurol. (2024) 532(3):e25599. 10.1002/cne.25599</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.25599</ArticleId><ArticleId IdType="pmc">PMC10958589</ArticleId><ArticleId IdType="pubmed">38488687</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhl EH, Oelschläger HA. Ontogenetic development of the nervus terminalis in toothed whales. Evidence for its non-olfactory nature. Anat Embryol (Berl). (1986) 173(3):285–94. 10.1007/BF00318911</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00318911</ArticleId><ArticleId IdType="pubmed">3963407</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelschläger HA, Buhl EH, Dann JF. Development of the nervus terminalis in mammals including toothed whales and humans. Ann N Y Acad Sci. (1987) 519:447–64. 10.1111/j.1749-6632.1987.tb36316.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1987.tb36316.x</ArticleId><ArticleId IdType="pubmed">3448969</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober A, Meyer DL, Von Bartheld CS. Central projections of the nervus terminalis and the nervus praeopticus in the lungfish brain revealed by nitric oxide synthase. J Comp Neurol. (1994) 349(1):1–19. 10.1002/cne.90349010224</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.90349010224</ArticleId><ArticleId IdType="pubmed">7531722</ArticleId></ArticleIdList></Reference><Reference><Citation>Singru PS, Sakharkar AJ, Subhedar N. Neuronal nitric oxide synthase in the olfactory system of an adult teleost fish Oreochromis mossambicus. Brain Res. (2003) 977(2):157–68. 10.1016/s0006-8993(03)02626-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-8993(03)02626-x</ArticleId><ArticleId IdType="pubmed">12834876</ArticleId></ArticleIdList></Reference><Reference><Citation>Brüne B. Nitric oxide: NO apoptosis or turning it ON? Cell Death Differ. (2003) 10(8):864–9. 10.1038/sj.cdd.4401261</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401261</ArticleId><ArticleId IdType="pubmed">12867993</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GC. Nitric oxide and neuronal death. Nitric Oxide. (2010) 23(3):153–65. 10.1016/j.niox.2010.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2010.06.001</ArticleId><ArticleId IdType="pubmed">20547235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho CY, Salimian M, Hegert J, O'Brien J, Choi SG, Ames H, et al. Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19. JAMA Neurol. (2022) 79(6):544–53. 10.1001/jamaneurol.2022.0154</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0154</ArticleId><ArticleId IdType="pmc">PMC9002725</ArticleId><ArticleId IdType="pubmed">35404378</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M, Kodra A, Hoagland DA, Frere J, Fullard JF, Shayya H, et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell. (2022) 185(6):1052–64.e12. 10.1016/j.cell.2022.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Parlak AE, Selçuk ÖT, Yilmaz GÖ, Aydenizoz D, Selçuk NT, Öcal R, et al. Olfactory bulb volume and morphology changes in COVID-19 patients with olfactory disorders using magnetic resonance imaging. J Comput Assist Tomogr. (2024) 48(2):317–22. 10.1097/RCT.0000000000001559</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RCT.0000000000001559</ArticleId><ArticleId IdType="pubmed">37876233</ArticleId></ArticleIdList></Reference><Reference><Citation>Güney B, Bacaksızlar Sarı F, Özdemir MY, Çullu N, Doğan E, Togan T. Changes in olfactory bulbus volume and olfactory sulcus depth in the chronic period after COVID-19 infection. Acta Otolaryngol. (2021) 141(8):786–90. 10.1080/00016489.2021.194613842</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2021.194613842</ArticleId><ArticleId IdType="pubmed">34289328</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O. Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol. (2021) 28(1):28–35. 10.1016/j.acra.2020.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC7571972</ArticleId><ArticleId IdType="pubmed">33132007</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshavarz P, Haseli S, Yazdanpanah F, Bagheri F, Raygani N, Karimi-Galougahi M. A systematic review of imaging studies in olfactory dysfunction secondary to COVID-19. Acad Radiol. (2021) 28(11):1530–40. 10.1016/j.acra.2021.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8403662</ArticleId><ArticleId IdType="pubmed">34548231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi S, Gouravani M, Salehi MA, Harandi H, Moosaie F, Dehghani Firouzabadi F, et al. Olfactory system measurements in COVID-19: a systematic review and meta-analysis. Neuroradiology. (2023) 65(1):25–39. 10.1007/s00234-022-03014-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-022-03014-8</ArticleId><ArticleId IdType="pmc">PMC9288925</ArticleId><ArticleId IdType="pubmed">35843987</ArticleId></ArticleIdList></Reference><Reference><Citation>Capelli S, Caroli A, Barletta A, Arrigoni A, Napolitano A, Pezzetti G, et al. MRI evidence of olfactory system alterations in patients with COVID-19 and neurological symptoms. J Neurol. (2023) 270(3):1195–206. 10.1007/s00415-023-11561-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11561-0</ArticleId><ArticleId IdType="pmc">PMC9850323</ArticleId><ArticleId IdType="pubmed">36656356</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, Gao Y, Feng Y, Sun Z, Yu Z. Assessment of factors influencing the olfactory bulb volume in patients with post-viral olfactory dysfunction. Eur Arch Otorhinolaryngol. (2023) 280(8):3737–43. 10.1007/s00405-023-07932-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-023-07932-y</ArticleId><ArticleId IdType="pubmed">37004522</ArticleId></ArticleIdList></Reference><Reference><Citation>Leboucq N, Menjot de Champfleur N, Menjot de Champfleur S, Bonafé A. The olfactory system. Diagn Interv Imaging. (2013) 94(10):985–91. 10.1016/j.diii.2013.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diii.2013.06.006</ArticleId><ArticleId IdType="pubmed">23932763</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institute of Health. Available online at:
https://www.covid19treatmentguidelines.nih.gov./accessed Feb 2023 (Accessed February 2023).</Citation></Reference><Reference><Citation>Eckstein K, Dymerska B, Bachrata B, Bogner W, Poljanc K, Trattnig S, et al. Computationally efficient combination of multi-channel phase data from multi-echo acquisitions (ASPIRE). Magn Reson Med. (2018) 79(6):2996–3006. 10.1002/mrm.26963</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.26963</ArticleId><ArticleId IdType="pubmed">29034511</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckstein K, Bachrata B, Hangel G, Widhalm G, Enzinger C, Barth M, et al. Improved susceptibility weighted imaging at ultra-high field using bipolar multi-echo acquisition and optimized image processing: CLEAR-SWI. Neuroimage. (2021) 237:118175. 10.1016/j.neuroimage.2021.118175</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2021.118175</ArticleId><ArticleId IdType="pmc">PMC7612087</ArticleId><ArticleId IdType="pubmed">34000407</ArticleId></ArticleIdList></Reference><Reference><Citation>Langan MT, Smith DA, Verma G, Khegai O, Saju S, Rashid S, et al. Semi-automated segmentation and quantification of perivascular spaces at 7 tesla in COVID-19. Front Neurol. (2022) 13:846957. 10.3389/fneur.2022.846957</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.846957</ArticleId><ArticleId IdType="pmc">PMC9010775</ArticleId><ArticleId IdType="pubmed">35432151</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragão MFVV, Leal MC, Cartaxo Filho OQ, Fonseca TM, Valença MM. Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI. AJNR Am J Neuroradiol. (2020) 41(9):1703–6. 10.3174/ajnr.A6675</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6675</ArticleId><ArticleId IdType="pmc">PMC7583088</ArticleId><ArticleId IdType="pubmed">32586960</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrêa DG, Hygino da Cruz LC Jr, Lopes FCR, Rangel CC, de Araújo Henriques Tessarollo AL, Coelho KCG, et al. Magnetic resonance imaging features of COVID-19-related cranial nerve lesions. J Neurovirol. (2021) 27(1):171–7. 10.1007/s13365-020-00934-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00934-0</ArticleId><ArticleId IdType="pmc">PMC7812977</ArticleId><ArticleId IdType="pubmed">33460014</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliezer M, Hamel AL, Houdart E, Herman P, Housset J, Jourdaine C, et al. Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts. Neurology. (2020) 95(23):e3145–52. 10.1212/WNL.0000000000010806</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010806</ArticleId><ArticleId IdType="pubmed">32917809</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao L, Yang Y, Yu W, Zhao Y, Long H, Gao J, et al. The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys. Signal Transduct Target Ther. (2021) 6(1):169. 10.1038/s41392-021-00591-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00591-7</ArticleId><ArticleId IdType="pmc">PMC8065334</ArticleId><ArticleId IdType="pubmed">33895780</ArticleId></ArticleIdList></Reference><Reference><Citation>Desiato VM, Levy DA, Byun YJ, Nguyen SA, Soler ZM, Schlosser RJ. The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis. Am J Rhinol Allergy. (2021) 35(2):195–205. 10.1177/1945892420946254</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1945892420946254</ArticleId><ArticleId IdType="pubmed">32746612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>